Lung transplantation is a suitable treatment to improve the quality of life and the prognosis of patients with various end-stage pulmonary diseases. There is a shortage of organs and the number of patients on waiting list is exceeding the number of transplants per year approximately two-fold in most countries. Strategies to increase the donor pool are therefore crucial. The long-term prognosis after lung transplantation is not yet as good as for other transplantation procedures and special complications should be taken into account. Aside from infections chronic organ dysfunction is the main cause of death and the most important prognosis limiting factor. Other typical problems are rejection, bronchus complications, and primary transplant dysfunction. However, the results of large centers show promising improvements in recent years.
Aris, R.M., Routh, J.C., LiPuma, J.J., Heath, D.G. and Gilligan, P.H. (2001) Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type, Am J Respir Crit Care Med. 164: 2102-2106.
2.
Boehler, A. and Estenne, M. (2003) Post-transplant bronchiolitis obliterans, Eur Respir J. 22: 1007-1018.
3.
Celli, B.R., Cote, C.G., Marin, J.M., Casanova, C., Montes, d. O., Mendez, R.A. et al. (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease , N Engl J Med. 350: 1005-1012.
4.
Chaparro, C., Maurer, J., Gutierrez, C., Krajden, M., Chan, C., Winton, T. et al. (2001) Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation, Am J Respir Crit Care Med. 163: 43-48.
5.
Charman, S.C., Sharples, L.D., McNeil, K.D. and Wallwork, J. (2002) Assessment of survival benefit after lung transplantation by patient diagnosis, J Heart Lung Transplant. 21: 226-232.
6.
Chhajed, P.N., Malouf, M.A. and Glanville, A.R. (2001) Bronchoscopic dilatation in the management of benign (non-transplant) tracheobronchial stenosis, Intern Med J. 31: 512-516.
7.
Chhajed, P.N., Malouf, M.A., Tamm, M. and Glanville, A.R. (2003) Ultraflex stents for the management of airway complications in lung transplant recipients, Respirology. 8: 59-64.
8.
Christie, J.D., Van Raemdonck, D., de Perrot, M., Barr, M., Keshavjee, S., Arcasoy, S. et al. (2005a) Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: introduction and methods, J Heart Lung Transplant. 24: 1451-1453.
9.
Christie, J.D., Kotloff, R.M., Ahya, V.N., Tino, G., Pochettino, A., Gaughan, C. et al. (2005b) The effect of primary graft dysfunction on survival after lung transplantation, Am J Respir Crit Care Med. 171: 1312-1316.
10.
Couraud, L., Nashef, S.A., Nicolini, P. and Jougon, J. (1992) Classification of airway anastomotic healing, Eur J Cardiothorac Surg. 6: 496-497.
11.
de Antonio, D.G., Marcos, R., Laporta, R., Mora, G., Garcia-Gallo, C., Gamez, P. et al. (2007) Results of clinical lung transplant from uncontrolled non-heart-beating donors, J Heart Lung Transplant . 26: 529-534.
12.
de Perrot, M., Snell, G.I., Babcock, W.D., Meyers, B.F., Patterson, G., Hodges, T.N. et al. (2004) Strategies to optimize the use of currently available lung donors, J Heart Lung Transplant. 23: 1127-1134.
13.
De Soyza, A. and Corris, P.A. (2003) Lung transplantation and the Burkholderia cepacia complex, J Heart Lung Transplant. 22: 954-958.
14.
Egan, T.M., Murray, S., Bustami, R.T., Shearon, T.H., McCullough, K.P., Edwards, L.B. et al. (2006) Development of the new lung allocation system in the United States, Am J Transplant. 6: 1212-1227.
15.
Estenne, M., Maurer, J.R., Boehler, A., Egan, J.J., Frost, A., Hertz, M. et al. (2002) Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria, J Heart Lung Transplant . 21: 297-310.
16.
Finkelstein, S.M., Scudiero, A., Lindgren, B., Snyder, M. and Hertz, M.I. (2005) Decision support for the triage of lung transplant recipients on the basis of home-monitoring spirometry and symptom reporting , Heart Lung. 34: 201-208.
17.
Fischer, S., Struber, M., Simon, A.R., Anssar, M., Wilhelmi, M., Leyh, R.G. et al. (2001) Video-assisted minimally invasive approach in clinical bilateral lung transplantation, J Thorac Cardiovasc Surg. 122: 1196-1198.
18.
Gerhardt, S.G., McDyer, J.F., Girgis, R.E., Conte, J.V., Yang, S.C. and Orens, J.B. (2003) Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study, Am J Respir Crit Care Med. 168: 121-125.
19.
Gottlieb, J.,Welte,T., Hoper, M.M., Struber, M. and Niedermeyer, J. (2004) [Lung transplantation. Possibilities and limitations] , Internist (Berl) 45: 1246-1259.
20.
Gries, C.J., Mulligan, M.S., Edelman, J.D., Raghu, G., Curtis, J.R. and Goss, C.H. (2007) Lung allocation score for lung transplantation: impact on disease severity and survival, Chest. 132: 1954-1961.
21.
Hachem, R.R.,Yusen, R.D., Chakinala, M.M., Meyers, B.F., Lynch, J.P., Aloush, A.A. et al. (2007) A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation, J Heart Lung Transplant. 26: 1012-1018.
22.
Hadjiliadis, D., Duane, D.R., Steele, M.P., Messier, R.H., Lau, C.L., Eubanks, S.S. et al. (2003) Gastroesophageal reflux disease in lung transplant recipients, Clin Transplant. 17: 363-368.
23.
Hadjiliadis, D., Steele, M.P., Chaparro, C., Singer, L.G., Waddell, T.K., Hutcheon, M.A. et al. (2007) Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria, J Heart Lung Transplant. 26: 834-838.
24.
Herrera, J.M., McNeil, K.D., Higgins, R.S., Coulden, R.A., Flower, C.D., Nashef, S.A. et al. (2001) Airway complications after lung transplantation: treatment and long-term outcome, Ann Thorac Surg. 71: 989-993.
25.
Hopkins, P.M., Aboyoun, C.L., Chhajed, P.N., Malouf, M.A., Plit, M.L., Rainer, S.P. et al. (2004) Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis, Am J Respir Crit Care Med. 170: 1022-1026.
26.
Keller, C.A., Hinerman, R., Singh, A. and Alvarez, F. (2001) The use of endoscopic argon plasma coagulation in airway complications after solid organ transplantation, Chest. 119: 1968-1975.
27.
Khalifah, A.P., Hachem, R.R., Chakinala, M.M., Schechtman, K.B., Patterson, G.A., Schuster, D.P. et al. (2004) Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death, Am J Respir Crit Care Med. 170: 181-187.
28.
Kugler, C., Fischer, S., Gottlieb, J., Welte, T., Simon, A., Haverich, A. et al. (2005) Health-related quality of life in two hundred-eighty lung transplant recipients, J Heart Lung Transplant24: 2262-2268.
29.
Madill, J., Gutierrez, C., Grossman, J., Allard, J., Chan, C., Hutcheon, M. et al. (2001) Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90-day mortality following transplantation , J Heart Lung Transplant20: 288-296.
30.
McNeil, K., Glanville, A.R., Wahlers, T., Knoop, C., Speich, R., Mamelok, R.D. et al. (2006) Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients, Transplantation81: 998-1003.
31.
Murthy, S.C., Blackstone, E.H., Gildea, T.R., Gonzalez-Stawinski, G.V., Feng, J., Budev, M. et al. (2007) Impact of anastomotic airway complications after lung transplantation, Ann Thorac Surg. 84: 401-409.
32.
Orens, J.B., Estenne, M., Arcasoy, S., Conte, J.V., Corris, P., Egan, J.J. et al. (2006) International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation , J Heart Lung Transplant. 25: 745-755.
33.
Palmer, S.M., Miralles, A.P., Howell, D.N., Brazer, S.R., Tapson, V.F. and Davis, R.D. (2000) Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation, Chest. 118: 1214-1217.
34.
Patterson, G.A. (2004) Living lobar lung transplantation: is it a necessary option? Am J Transplant. 4: 1213-1214.
35.
Sharples, L.D., McNeil, K., Stewart, S. and Wallwork, J. (2002) Risk factors for bronchiolitis obliterans: a systematic review of recent publications, J Heart Lung Transplant. 21: 271-281.
36.
Shitrit, D., Bendayan, D., Gidon, S., Saute, M., Bakal, I. and Kramer, M.R. (2005) Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients, J Heart Lung Transplant. 24: 1440-1443.
37.
Snell, G.I., Valentine, V.G., Vitulo, P., Glanville, A.R., McGiffin, D.C., Loyd, J.E. et al. (2006) Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial, Am J Transplant. 6: 169-177.
38.
Snell, G.I., Boehler, A., Glanville, A.R., McNeil, K., Scott, J.P., Studer, S.M. et al. (2007) Eleven years on: a clinical update of key areas of the 1996 lung allograft rejection working formulation, J Heart Lung Transplant. 26: 423-430.
39.
Tegtbur, U., Sievers, C., Busse, M.W., Pethig, K., Warnecke, G., Kugler, C. et al. (2004) [Quality of life and exercise capacity in lung transplant recipients]. Pneumologie. 58: 72-78.
40.
Trulock, E.P., Christie, J.D., Edwards, L.B., Boucek, M.M., Aurora, P., Taylor, D.O. et al. (2007) Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant. 26: 782-795.
41.
Van De Wauver , C., Van Raemdonck, D., Verleden, G.M., Dupont, L., De Leyn, P., Coosemans, W. et al. (2007) Risk factors for airway complications within the first year after lung transplantation, Eur J Cardiothorac Surg. 31: 703-710.
42.
Verleden, G.M. and Dupont, L.J. (2004) Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation . 77: 1465-1467.
43.
Verleden, G.M., Vanaudenaerde, B.M., Dupont, L.J. and Van Raemdonck, D.E. (2006) Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome , Am J Respir Crit Care Med. 174: 566-570.
44.
Yates, B., Murphy, D.M., Forrest, I.A., Ward, C., Rutherford, R.M., Fisher, A.J. et al. (2005) Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome, Am J Respir Crit Care Med. 172: 772-775.
45.
Zamora, M.R. (2002) Controversies in lung transplantation: management of cytomegalovirus infections, J Heart Lung Transplant. 21: 841-849.
46.
Zorn Jr, G.L., McGiffin, D.C.,Young Jr, K.R., Alexander, C.B., Weill, D. and Kirklin, J.K. (2003) Pulmonary transplantation for advanced bronchioloalveolar carcinoma, J Thorac Cardiovasc Surg. 125: 45-48.
